Centiva Capital LP Has $4.55 Million Stock Position in Danaher Co. (NYSE:DHR)

Centiva Capital LP increased its stake in Danaher Co. (NYSE:DHR) by 286.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 16,365 shares of the conglomerate’s stock after buying an additional 12,125 shares during the quarter. Centiva Capital LP’s holdings in Danaher were worth $4,550,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Cinctive Capital Management LP acquired a new stake in Danaher in the third quarter valued at $7,697,000. Concentric Capital Strategies LP increased its stake in shares of Danaher by 203.4% during the 3rd quarter. Concentric Capital Strategies LP now owns 7,182 shares of the conglomerate’s stock worth $1,997,000 after purchasing an additional 4,815 shares during the last quarter. Arvin Capital Management LP bought a new stake in shares of Danaher in the 3rd quarter valued at about $8,666,000. Ascent Group LLC lifted its stake in Danaher by 2.9% in the 3rd quarter. Ascent Group LLC now owns 2,270 shares of the conglomerate’s stock valued at $631,000 after purchasing an additional 65 shares during the last quarter. Finally, Benjamin Edwards Inc. grew its holdings in Danaher by 526.8% during the third quarter. Benjamin Edwards Inc. now owns 13,496 shares of the conglomerate’s stock worth $3,753,000 after purchasing an additional 11,343 shares during the period. 79.05% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Wells Fargo & Company began coverage on Danaher in a research note on Tuesday, August 27th. They issued an “equal weight” rating and a $280.00 price objective on the stock. Robert W. Baird dropped their price target on Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Evercore ISI raised their price target on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. UBS Group decreased their price objective on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. Finally, KeyCorp raised their target price on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $287.16.

Danaher Stock Performance

NYSE DHR opened at $239.00 on Monday. Danaher Co. has a 1 year low of $215.68 and a 1 year high of $281.70. The firm has a market capitalization of $172.62 billion, a price-to-earnings ratio of 45.74, a P/E/G ratio of 4.41 and a beta of 0.85. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The firm’s 50 day simple moving average is $254.59 and its 200 day simple moving average is $259.41.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same quarter last year, the company posted $2.02 EPS. The company’s revenue for the quarter was up 3.1% compared to the same quarter last year. As a group, research analysts expect that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. Danaher’s dividend payout ratio (DPR) is currently 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.